.
MergerLinks Header Logo

New Deal


Announced

Completed

Bain Capital, and Cinven, to make an offer for the 63% of STADA Arzneimittel AG's shares.

Financials

Edit Data
Transaction Value£2,891m
Consideration TypeCash
Capital Owned-
Capital Bid For64%
EV/Sales2.4x
EV/EBITDA13x
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

generic drugmaker

Pharmaceuticals

Germany

Public

Acquisition

Completed

Friendly

Private Equity

Majority

Synopsis

Edit

Bain Capital, private equity firm, and Cinven, private equity firm, acquired 63% of the outstanding shares of the German generic drugmaker STADA Arzneimittel.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US